How to Buy Insulet Stock
Insulet Corp
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
Insulet stock last closed at $238.57, down 3.33% from the previous day, and has increased 45.1% in one year. It has overperformed other stocks in the Medical Devices industry by 0.64 percentage points. Insulet stock is currently +48.93% from its 52-week low of $160.19, and -17.58% from its 52-week high of $289.46.
As of Apr 21, 2025, there are 70.23M PODD shares outstanding. The market cap of PODD is $16.75B. In the last 24 hours, 516,121 PODD shares were traded.
How to Buy Insulet Stock
Not sure how to invest in Insulet stock? Here's how.
- Decide where to buy Insulet stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Insulet stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Choose your payment method and add your info.
- Research Insulet stock: The Insulet ticker symbol is PODD. Is Insulet stock a good investment? Should you buy shares of PODD? How do PODD's underlying business fundamentals look? Do top analysts think Insulet is a good buy? Why has PODD's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if PODD is a good stock to buy).
- Execute your PODD purchase: Decide if you will purchase PODD shares at the current market price or use a limit order to buy PODD shares at a given price.
- Get notifications regarding your PODD position: Create a watchlist to monitor your position in Insulet shares.
Step 1: Decide where to buy Insulet stock
You will need an online brokerage account to access the NASDAQ market and buy PODD stock.
Our favorite brokerage: eToro
We believe that eToro is the best stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal information so you are able to buy PODD stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create your new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have filled out your info on a good online stock trading app, your next step is to transfer the money for your investment:
Watch the walkthrough below to see the process of depositing funds into your new investment account.
Step 4: Research Insulet stock
Once you have chosen the best place to buy Insulet stock, it's critical to analyze their stock before you invest, so you can wrap your head around the risk and opportunity.
Overview of key PODD info
PODD Overview
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on PODD's stock page.
What is the fair value of PODD stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge PODD's true value.
Using relative valuations ratios:
- PODD could be undervalued based on its P/E ratio of 39.96x, relative to Medical Devices industry P/E ratio of 40.34x
- PODD could be overvalued based on its P/B ratio of 13.83x, relative to Medical Devices industry P/B ratio of 3.74x
- PODD could be overvalued based on its PEG ratio of 17.66x
You can access additional valuation analysis on PODD's stock here.
PODD Financial Health Overview
Passed Financial Due Diligence Checks:
- PODD profit margin has gone up from 12.2% to 20.2% in the past year.
- There are more short-term assets than long-term liabilities on the PODD balance sheet.
- Total PODD debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the PODD balance sheet.
- PODD earnings of $342.90M is not enough to cover its interest payments.
- PODD's operating cash flow of $430.30M allows it to safely service it's debt of $1.38B.
Failed Financial Due Diligence Checks:
- PODD has a relatively high debt to equity ratio of 1.55.
Is it a good time to buy Insulet stock, according to Wall Street analysts?
Out of 14 Wall Street analysts who track PODD, the consensus analyst rating on Insulet is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Latest PODD Analyst Upgrades/Downgrades
Lawrence Biegelsen, a bottom 12% analyst from Wells Fargo maintains PODD with a strong buy rating and raises their PODD price target from $305.00 to $322.00, on Feb 21, 2025.
Kyle Rose, a top 10% analyst from Canaccord Genuity maintains PODD with a strong buy rating and raises their PODD price target from $304.00 to $324.00, on Feb 21, 2025.
Canaccord Genuity's Kyle Rose raised their price target on Insulet (NASDAQ: PODD) by 6.6% from $304 to $324 on 2025/02/21. The analyst maintained their Strong Buy rating on the stock.
Insulet reported its Q4 and FY 2024 earnings.
The company's Q4 performance was strong while management's FY 2025 guidance was consistent with expectations, Rose told readers.
However, the analyst argued that investors were primarily concerned with the rather modest U.S. Omnipod revenue guidance.
Nonetheless, factors Rose cited for their bullish view that the company is well-positioned to profit from the type 2 diabetes population included:
- Insulet's unique form factor.
- Distribution channel (pharmacy).
- First-in-kind insulin delivery unit (IFU).
Earnings Report
Insulet reported:
For Q4 2024:
- EPS of $1.15, which beat the Zacks Consensus Estimate of $1.05 but missed, by 17.9%, Q4 2023’s $1.40.
- Revenue of $597.5M, which beat the Zacks Consensus Estimate by 2.73% and, by 17.2%, Q4 2023’s $509.8M.
For FY 2024:
- EPS of $3.24, up 17.8% Y/Y.
- Revenue of $2.1B, up 22.1% Y/Y.
Management guided:
For Q1 2025:
- Revenue growth of 22% to 25%.
For FY 2025:
- Revenue growth of 16% to 20%.
President & CEO Jim Hollingshead commented: "We concluded an incredible year with a very strong Q4, achieving significant milestones across the business, and exceeding our growth and margin objectives.
"We continue to see robust demand and momentum for Omnipod 5, now available to both type 1 and type 2 patients in the U.S., and we continue to expand in international markets.
“We generated more than $2B in FY revenue for the first time in Insulet’s history, reached more customers, and continued to expand margins.”
Joshua Jennings, a top 24% analyst from TD Cowen maintains PODD with a strong buy rating and raises their PODD price target from $264.00 to $324.00, on Jan 3, 2025.
Robbie Marcus, a top 20% analyst from JP Morgan maintains PODD with a strong buy rating and raises their PODD price target from $280.00 to $330.00, on Dec 12, 2024.
William Plovanic, a top 16% analyst from Canaccord Genuity maintains PODD with a strong buy rating and raises their PODD price target from $269.00 to $304.00, on Dec 9, 2024.
You can dig deeper into what analysts are saying on the Insulet stock forecast page.
PODD Trading Indicators
How is PODD performing as a company?
Last year, PODD earnings were $418.30M. In the last five year, PODD's earnings have increased by 99.27% per year. This was faster than the Medical Devices industry average of 10.23%.
Last year, PODD revenue was $2.07B. During the past 5 year, PODD's revenue has increased by 22.92% per year. This was faster than the Medical Devices industry average of 9.8%.
You can research PODD's earnings and revenue performance here.
Who is buying/selling PODD?
Over the last 12 months, insiders at PODD have sold more shares than they have bought.
Wayne Ai Frederick, Director of PODD, was the latest PODD insider to sell. They sold $501,875.00 worth of PODD shares on Mar 25, 2025.
Dig into more about who owns PODD stock here.
Can I rely on PODD as an income stream?
No, Insulet doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your PODD purchase
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open button and eToro will execute the order.
If you need more help investing in stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your PODD position
Now that you own some shares in PODD, you'll want to stay up-to-date on your new investment.
Add PODD to a watchlist to see the latest developments about your PODD stock.
PODD Feed
How to Buy Stock in Insulet
To reiterate, here are the 6 steps to buy Insulet stock:
- Decide where to buy Insulet stock
- Open a brokerage account
- Put funds into your brokerage account
- Research Insulet stock
- Execute your PODD purchase
- Get notifications regarding your PODD position
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Insulet, create a watchlist today.
Other "How To" Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.